Haruki Kitazawa Selected Research

Haruki Kitazawa Research Topics

Disease

13	Inflammation (Inflammations) 04/2021 - 01/2012
11	Infections 03/2021 - 09/2012
7	Porcine Reproductive and Respiratory Syndrome (PRRS) 03/2020 - 01/2014
7	Respiratory Syncytial Virus Infections 01/2020 - 08/2013
5	Virus Diseases (Viral Diseases) 01/2020 - 09/2012
3	Lung Injury 06/2021 - 09/2012
3	Superinfection 01/2021 - 01/2017
3	Pneumococcal Pneumonia 01/2020 - 01/2017
2	COVID-19 09/2021 - 03/2021
2	Pneumococcal Infections 06/2021 - 05/2020
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2021 - 11/2015
2	Rotavirus Infections 01/2021 - 01/2016
2	Mastitis 05/2020 - 03/2020
2	Insulin Resistance 01/2020 - 01/2016
2	Obesity 01/2020 - 01/2016
2	Colitis 01/2020 - 11/2015
2	Pneumonia (Pneumonitis) 01/2017 - 09/2012
2	Mycoplasmal Pneumonia of Swine (Swine Mycoplasmal Pneumonia) 04/2014 - 10/2013
1	Coronavirus Infections 05/2021
1	Bovine Mastitis 05/2020
1	Mycotoxicosis (Fungus Poisoning) 01/2020
1	Communicable Diseases (Infectious Diseases) 01/2017
1	Bacteremia 01/2017
1	Hyperglycemia 01/2016
1	Weight Gain 01/2016
1	Atopic Dermatitis (Atopic Eczema) 02/2015
1	B-Cell Lymphoma (Lymphoma, B Cell) 03/2013
1	Asthma (Bronchial Asthma) 06/2012
1	Prion Diseases (Transmissible Spongiform Encephalopathies) 03/2007
1	Necrosis 03/2005

Drug/Important Bio-Agent (IBA)

11	Antiviral Agents (Antivirals)IBA 01/2021 - 09/2012
9	CytokinesIBA 06/2021 - 06/2012
7	Toll-Like Receptors (Toll-Like Receptor)IBA 05/2020 - 12/2013
7	Pattern Recognition ReceptorsIBA 03/2020 - 01/2014
4	Interleukin-10 (Interleukin 10)IBA 01/2020 - 09/2012
3	Poly I-CIBA 09/2021 - 09/2012
3	VaccinesIBA 03/2021 - 10/2013
3	Proteins (Proteins, Gene)FDA Link 03/2020 - 03/2005
3	Peptidoglycan (Murein)IBA 01/2020 - 01/2017
3	Toll-Like Receptor 3IBA 01/2020 - 01/2016
3	InterferonsIBA 01/2020 - 01/2014
2	sodium sulfate (sodium bisulfate)FDA LinkGeneric 01/2021 - 01/2020
2	Dextrans (Dextran)FDA Link 01/2021 - 01/2020
2	Interleukin-27 (Interleukin 27)IBA 01/2020 - 01/2017
2	Interleukin-17 (Interleukin 17)IBA 01/2020 - 06/2012
2	Interleukin-6 (Interleukin 6)IBA 01/2020 - 09/2012
2	Interferon Type IIBA 01/2020 - 01/2020
2	Biomarkers (Surrogate Marker)IBA 01/2020 - 01/2017
2	MD1IBA 08/2016 - 03/2015
2	InterleukinsIBA 01/2014 - 03/2005
2	Pathogen-Associated Molecular Pattern MoleculesIBA 03/2013 - 09/2012
1	Carbapenems (Carbapenem Antibiotics)IBA 01/2021
1	Anti-Bacterial Agents (Antibiotics)IBA 05/2020
1	Cyclophilin AIBA 03/2020
1	LipopeptidesIBA 03/2020
1	Toll-Like Receptor 2IBA 03/2020
1	ChemokinesIBA 03/2020
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2020
1	AdipokinesIBA 01/2020
1	AntibodiesIBA 01/2020
1	MycotoxinsIBA 01/2020
1	LigandsIBA 01/2019
1	peptidoglycan recognition proteinIBA 01/2019
1	lipoteichoic acidIBA 01/2019
1	LipopolysaccharidesIBA 01/2019
1	2-5A-dependent ribonuclease (RNase L)IBA 01/2016
1	Glucose (Dextrose)FDA LinkGeneric 01/2016
1	Serotonin (5 Hydroxytryptamine)IBA 01/2016
1	Dextran SulfateIBA 11/2015
1	Heme Oxygenase-1IBA 11/2015
1	NanocapsulesIBA 02/2015
1	OligodeoxyribonucleotidesIBA 02/2015
1	Phenobarbital (Luminal)FDA Link 01/2014
1	AntigensIBA 10/2013
1	Viral RNAIBA 09/2012
1	Interleukin-8 (Interleukin 8)IBA 09/2012
1	CXC ChemokinesIBA 06/2012
1	Toll-Like Receptor 4IBA 01/2012
1	Prion ProteinsIBA 03/2007
1	ODN ID35IBA 03/2005
1	Interferon-gamma (Interferon, gamma)IBA 03/2005
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2005
1	Interleukin-12 (IL 12)IBA 03/2005
1	Messenger RNA (mRNA)IBA 03/2005
1	Interleukin-18 (Interleukin 18)IBA 03/2005

Therapy/Procedure

3	Oral Administration 01/2020 - 10/2013
1	Therapeutics 05/2020
1	Intraperitoneal Injections 01/2016
1	Intranasal Administration 08/2015